Epidemiology, Pathophysiology, Diagnosis and Management of Chronic Right-Sided Heart Failure and Tricuspid Regurgitation. A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC.

Adamo, Marianna; Chioncel, Ovidiu; Pagnesi, Matteo; Bayes-Genis, Antoni; Abdelhamid, Magdy; Anker, Stefan D; Antohi, Elena-Laura; Badano, Luigi; Ben Gal, Tuvia; Böhm, Michael; Delgado, Victoria; Dreyfus, Julien; Faletra, Francesco F; Farmakis, Dimitrios; Filippatos, Gerasimos; Grapsa, Julia; Gustafsson, Finn; Hausleiter, Jörg; Jaarsma, Tiny; Karam, Nicole; ... (2024). Epidemiology, Pathophysiology, Diagnosis and Management of Chronic Right-Sided Heart Failure and Tricuspid Regurgitation. A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC. European journal of heart failure, 26(1), pp. 18-33. Wiley 10.1002/ejhf.3106

Text European_J_of_Heart_Fail_-_2023_-_Adamo_-_Epidemiology__Pathophysiology__Diagnosis_and_Management_of_Chronic_Right_Sided.pdf - Accepted Version Restricted to registered users only until 22 December 2024. Available under License Publisher holds Copyright. Download (1MB) | Request a copy

Right-sided heart failure and tricuspid regurgitation are common and strongly associated with poor quality of life and an increased risk of heart failure hospitalizations and death. While medical therapy for right-sided heart failure is limited, treatment options for tricuspid regurgitation include surgery and, based on recent developments, several transcatheter interventions. However, the patients who might benefit from tricuspid valve interventions are yet unknown, as is the ideal time for these treatments given the paucity of clinical evidence. In this context, it is crucial to elucidate etiology and pathophysiological mechanisms leading to right-sided heart failure and tricuspid regurgitation in order to recognize when tricuspid regurgitation is a mere bystander and when it can cause or contribute to heart failure progression. Notably, early identification of right heart failure and tricuspid regurgitation may be crucial and optimal management requires knowledge about the different mechanisms and causes, clinical course and presentation, as well as possible treatment options. The aim of this clinical consensus statement is to summarize current knowledge about epidemiology, pathophysiology and treatment of tricuspid regurgitation in right-sided heart failure providing practical suggestions for patient identification and management. This article is protected by copyright. All rights reserved.

Interest & Impact

Downloads

0 since deposited on 27 Dec 2023
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item